Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods
Licensed glycoconjugate vaccines are generally prepared using native or sized polysaccharides coupled to a carrier protein through random linkages along the polysaccharide chain. These polysaccharides must be chemically modified before covalent linking to a carrier protein in order to obtain a more...
Main Authors: | Victor Morais, Norma Suarez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/9/12/774 |
Similar Items
-
Activation of Soluble Polysaccharides with 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP) for Use in Protein–Polysaccharide Conjugate Vaccines and Immunological Reagents. III Optimization of CDAP Activation
by: Andrew Lees, et al.
Published: (2020-12-01) -
Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines
by: Francesca Micoli, et al.
Published: (2023-05-01) -
Site-Specific Conjugation for Fully Controlled Glycoconjugate Vaccine Preparation
by: Aline Pillot, et al.
Published: (2019-11-01) -
Glycoconjugate vaccines against antimicrobial resistant pathogens
by: Charlotte Sorieul, et al.
Published: (2023-12-01) -
Carriers and Antigens: New Developments in Glycoconjugate Vaccines
by: Robert M.F. van der Put, et al.
Published: (2023-01-01)